In Community-Based Study, Switching to Ixazomib in Newly Diagnosed MM Brought Improved Responses Across Age GroupsJanuary 25th 2023
An analysis presented during the 64th American Society of Hematology Annual Meeting and Exposition showed that patients with multiple myeloma were able to experience improved responses to the proteasome inhibitor ixazomib after switching from bortezomib.
The Center for Cancer and Blood Disorders Joins the American Oncology NetworkMay 5th 2020
American Oncology Network, LLC (AON) is pleased to announce that The Center for Cancer and Blood Disorders (CCBD), a leading community oncology and hematology practice serving Bethesda and Germantown, Maryland, has joined AON.
Vista Oncology Has Joined the American Oncology Network, LLCDecember 5th 2019
American Oncology Network, LLC (AON) is pleased to announce that Vista Oncology, a leading community oncology/hematology practice serving the Olympia, Washington community, has joined AON, effective December 1, 2019.
American Oncology Network Expands Participation in Oncology Care ModelNovember 26th 2019
Since its inception in 2017, the American Oncology Network, LLC (AON) has participated in the Oncology Care Model (OCM), a national innovative payment program of the Center for Medicare & Medicaid Innovation (CMMI).
Heartland Oncology & Hematology to Join the American Oncology Network, LLCOctober 17th 2019
American Oncology Network, LLC (AON) is pleased to announce that Heartland Oncology & Hematology, a leading community oncology/hematology practice in Council Bluffs, Iowa, will be joining AON, effective November 1, 2019.